GUGGENHIME ANDREW

CIK 00012307247 companiesSAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001230724

Recent Transactions

50 trades

Gift
Vaxcyte, Inc.$PCVX
Common Stock
2026-01-14−61,850→ 62,459 total
Gift
Vaxcyte, Inc.$PCVX
Common Stock
2026-01-14+61,850→ 61,850 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-08$32.41/sh−2,890→ 124,309 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-02$31.56/sh−1,429→ 127,199 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-02$31.56/sh−2,381→ 128,628 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-02$31.56/sh−1,270→ 131,009 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2025-04-07$20.93/sh+4,777→ 131,950 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-04-07−4,777→ 121,115 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-03$72.10/sh−3,809→ 127,173 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-28$73.02/sh−1,270→ 130,982 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-27+22,761→ 132,252 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-02-27+75,991→ 75,991 total
Award
Caribou Biosciences, Inc.$CRBU
Option to purchase Common Stock
2025-02-20+40,500→ 40,500 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-18$5.35/sh+8,000→ 117,491 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-18$83.64/sh−6,182→ 111,309 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-18$84.58/sh−1,818→ 109,491 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-02-18−8,000→ 246,827 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-21$5.35/sh+8,000→ 117,491 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-21$86.08/sh−5,318→ 112,173 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-21$87.25/sh−1,999→ 110,174 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-01-21−8,000→ 254,827 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-21$87.70/sh−683→ 109,491 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-12-18−8,000→ 262,827 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-18$5.35/sh+8,000→ 117,491 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-18$89.31/sh−3,157→ 109,771 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-18$88.70/sh−3,373→ 112,928 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-18$90.24/sh−280→ 109,491 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-18$87.26/sh−1,190→ 116,301 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-11-18−8,000→ 270,827 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-18$87.05/sh−132→ 109,491 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-18$85.59/sh−6,111→ 111,380 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-18$86.49/sh−1,757→ 109,623 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-18$5.35/sh+8,000→ 117,491 total
Award
Vaxcyte, Inc.$PCVX
Performance Stock Option (right to buy)
2024-11-07+87,481→ 87,481 total
Award
Vaxcyte, Inc.$PCVX
Performance Restricted Stock Units
2024-11-07+35,661→ 35,661 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-25−19,108→ 125,892 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-25$20.93/sh+19,108→ 109,491 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-18−8,000→ 304,827 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-18−8,000→ 312,827 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-18$115.26/sh−36,114→ 96,269 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-18$5.35/sh+8,000→ 98,383 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-18$116.19/sh−5,886→ 90,383 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-18$5.35/sh+14,000→ 132,383 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-18$5.35/sh+8,000→ 106,383 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-18−14,000→ 278,827 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-18$5.35/sh+12,000→ 118,383 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-18−12,000→ 292,827 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-18$115.60/sh−5,485→ 92,898 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-18$117.53/sh−829→ 90,383 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-18$116.29/sh−1,686→ 91,212 total

Companies

Recent Filings

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300

SAN CARLOS, CA, 94070

View on SEC.gov